Blue Venture Fund will exit the cancer diagnostics technology startup in a purchase by another of its investors, Exact Sciences, that could reach $2.15bn.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
UVC Partners levels up with $178m fund
Lanxness contributed to the third fund to be closed by venture firm UVC Partners which will back business-to-business software, industrial and mobility technology startups.
V2Food dishes up $55m series B
Esenagro contributed to a round that lifted the vegan mince and meat producer’s overall funding to nearly $80m in the past year.
Topas tackles series B round
Evotec and Boehringer Ingelheim Venture Fund returned in a $25.9m round for the autoimmune disease drug developer having first invested three years ago.
Ozon opens up to IPO possibilities
The Sistema-backed e-commerce marketplace has confidentially filed for an initial public offering in the US that would value it at $3bn to $5bn.
Roblox to roll to IPO
Tencent-backed online gaming platform developer Roblox is in talks over an IPO or direct listing at a valuation of up to $8bn.
Corporate venturing deal net: 28 September-2 October 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Northvolt recharges funding with $600m
Volkswagen has co-led a $600m round for Northvolt together with Baillie Gifford and Goldman Sachs, while Scania also returned.
VTex integrates $225m series D
Existing shareholder SoftBank has doubled down on its commitment to VTex by backing a $225m series D round that pushed the retail management platform’s valuation to $1.7bn.
Ayala activates $180m fund
Ayala has anchored the fund, while Globe Telecom also invested and helped push the fund past its original $150m target to make it the Philippines’ largest vehicle to date.
Nippon Life makes an impact with $100m
The insurance provider has committed $100m to the Life Science Impact Program, which is managed by Grove Street Advisors and will focus on healthcare businesses.
Sonoma secures series A extension
Lyell Immunopharma was joined by new corporate backers Lilly Asia Ventures Biosciences and Alexandria Venture Investments to bring Sonoma’s series A round to $70m.
CSS to captivate startups with $54m fund
The insurer has put $54m into a corporate venturing arm called SwissHealth Ventures to target digital health startups.
Cazoo captures $308m
DMG Ventures has contributed to a $308m funding round that increased Cazoo’s overall funding to some $558m and its valuation to more than $2.5bn.